BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 16000328)

  • 21. The absence of functional PI3Kgamma prevents leukocyte recruitment and ameliorates DSS-induced colitis in mice.
    van Dop WA; Marengo S; te Velde AA; Ciraolo E; Franco I; ten Kate FJ; Boeckxstaens GE; Hardwick JC; Hommes DW; Hirsch E; van den Brink GR
    Immunol Lett; 2010 Jun; 131(1):33-9. PubMed ID: 20347874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression.
    Kwon KH; Murakami A; Tanaka T; Ohigashi H
    Biochem Pharmacol; 2005 Feb; 69(3):395-406. PubMed ID: 15652231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemokine receptor blockade with a synthetic nonpeptide compound attenuates cardiac allograft vasculopathy.
    Bastani S; Sherman W; Schnickel GT; Hsieh GR; Bhatia R; Fishbein MC; Ardehali A
    Transplantation; 2009 Oct; 88(8):995-1001. PubMed ID: 19855245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of blocking the chemokine receptors, CCR5 and CXCR3, With TAK-779 in a rat small intestinal transplantation model.
    Xu H; Firdawes S; Yamamoto A; Zhao Y; Ihara Y; Uehara S; Matsunami K; Otsuka H; Fukuzawa M; Miyagawa S
    Transplantation; 2008 Dec; 86(12):1810-7. PubMed ID: 19104427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice.
    Sugimoto K; Hanai H; Tozawa K; Aoshi T; Uchijima M; Nagata T; Koide Y
    Gastroenterology; 2002 Dec; 123(6):1912-22. PubMed ID: 12454848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DA-6034, a derivative of flavonoid, prevents and ameliorates dextran sulfate sodium-induced colitis and inhibits colon carcinogenesis.
    Nam SY; Kim JS; Kim JM; Lee JY; Kim N; Jung HC; Song IS
    Exp Biol Med (Maywood); 2008 Feb; 233(2):180-91. PubMed ID: 18222973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adiponectin deficiency protects mice from chemically induced colonic inflammation.
    Fayad R; Pini M; Sennello JA; Cabay RJ; Chan L; Xu A; Fantuzzi G
    Gastroenterology; 2007 Feb; 132(2):601-14. PubMed ID: 17258715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pivotal roles of interleukin-6 in transmural inflammation in murine T cell transfer colitis.
    Kitamura K; Nakamoto Y; Kaneko S; Mukaida N
    J Leukoc Biol; 2004 Dec; 76(6):1111-7. PubMed ID: 15339938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis.
    Yadav M; Huang MC; Goetzl EJ
    Cell Immunol; 2011; 267(2):124-32. PubMed ID: 21295288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deletion of CCR2 but not CCR5 or CXCR3 inhibits aortic aneurysm formation.
    MacTaggart JN; Xiong W; Knispel R; Baxter BT
    Surgery; 2007 Aug; 142(2):284-8. PubMed ID: 17689697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection.
    Yun JJ; Whiting D; Fischbein MP; Banerji A; Irie Y; Stein D; Fishbein MC; Proudfoot AE; Laks H; Berliner JA; Ardehali A
    Circulation; 2004 Feb; 109(7):932-7. PubMed ID: 14757698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lactococcus lactis subsp. cremoris FC alleviates symptoms of colitis induced by dextran sulfate sodium in mice.
    Nishitani Y; Tanoue T; Yamada K; Ishida T; Yoshida M; Azuma T; Mizuno M
    Int Immunopharmacol; 2009 Nov; 9(12):1444-51. PubMed ID: 19733697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic effect of blocking CXCR2 on neutrophil recruitment and dextran sodium sulfate-induced colitis.
    Farooq SM; Stillie R; Svensson M; Svanborg C; Strieter RM; Stadnyk AW
    J Pharmacol Exp Ther; 2009 Apr; 329(1):123-9. PubMed ID: 19131582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minocycline attenuates experimental colitis in mice by blocking expression of inducible nitric oxide synthase and matrix metalloproteinases.
    Huang TY; Chu HC; Lin YL; Lin CK; Hsieh TY; Chang WK; Chao YC; Liao CL
    Toxicol Appl Pharmacol; 2009 May; 237(1):69-82. PubMed ID: 19285099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The interleukin-1 beta-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation.
    Loher F; Bauer C; Landauer N; Schmall K; Siegmund B; Lehr HA; Dauer M; Schoenharting M; Endres S; Eigler A
    J Pharmacol Exp Ther; 2004 Feb; 308(2):583-90. PubMed ID: 14610233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemokine and toll-like receptor signaling in macrophage mediated islet xenograft rejection.
    Chandra AP; Ouyang L; Yi S; Wong JK; Ha H; Walters SN; Patel AT; Stokes R; Jardine M; Hawthorne WJ; O'Connell PJ
    Xenotransplantation; 2007 Jan; 14(1):48-59. PubMed ID: 17214704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attenuation of acute experimental colitis by preventing NPY Y1 receptor signaling.
    Hassani H; Lucas G; Rozell B; Ernfors P
    Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G550-6. PubMed ID: 15499082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Essential roles of IL-6 trans-signaling in colonic epithelial cells, induced by the IL-6/soluble-IL-6 receptor derived from lamina propria macrophages, on the development of colitis-associated premalignant cancer in a murine model.
    Matsumoto S; Hara T; Mitsuyama K; Yamamoto M; Tsuruta O; Sata M; Scheller J; Rose-John S; Kado S; Takada T
    J Immunol; 2010 Feb; 184(3):1543-51. PubMed ID: 20042582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reactivation of inflammatory bowel disease in a mouse model of depression.
    Ghia JE; Blennerhassett P; Deng Y; Verdu EF; Khan WI; Collins SM
    Gastroenterology; 2009 Jun; 136(7):2280-2288.e1-4. PubMed ID: 19272381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic potency of IL2-caspase 3 targeted treatment in a murine experimental model of inflammatory bowel disease.
    Shteingart S; Rapoport M; Grodzovski I; Sabag O; Lichtenstein M; Eavri R; Lorberboum-Galski H
    Gut; 2009 Jun; 58(6):790-8. PubMed ID: 18978179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.